Web期刊名称. CURR CANCER DRUG TAR/CURRENT CANCER DRUG TARGETS. ISSN. 1568-0096. 影响指数话题. 影响指数话题. 预警等级. MedSci期刊指数. 8.434 (MedSci实 … Web在文章类型上,论著和综述文章是大头,数量参半,还有少量的社论文章。Web of Science已收录的文章中,论著文章1308篇,综述文章1109篇。 影响因子. 2024年6月,Cancers与Cells杂志同时获得首个SCI影响因子,Cancers的分数略高,而且破5分,这关注度自然要更 …
CURRENT CANCER DRUG TARGETS-期刊介绍-MedSci.cn
WebCurr Cancer Drug Targets. 2024;21(7):558-574. doi: 10.2174/1568009621666210504091722. ... The microenvironment of gliomas includes non-cancer cells such as immune cells, fibroblasts, and cells of blood vessels, as well as secreted molecules and the extracellular matrix, and all these components play a vital … WebCurrent Cancer Drug Targets. ISSN (Print): 1568-0096. ISSN (Online): 1873-5576. Volume 23 , Issues 11, 2024. This journal supports open access. Back Journal Home Purchase Full Issue. Submit Abstracts Submit Manuscripts. keyboard shortcut for overline
Current Cancer Drug Targets Bentham Science
WebTargeting the ubiquitin-proteasome pathway has emerged as a rational approach in the treatment of human cancer. Based on positive preclinical and clinical studies, bortezomib was subsequently approved for the clinical use as a front-line treatment for newly diagnosed multiple myeloma patients and for the treatment of relapsed/refractory multiple myeloma … WebCurr Cancer Drug Targets. 2013 Jan;13(1):30-47. Authors ... Other drugs to consider are thalidomide, lenalidomide, antiangiogenic agents, tyrosine kinase inhibitors and heat shock protein 90 inhibitors, which all have both antileukemic and immunomodulatory effects. Relatively few clinical studies are available for patients with this high-risk ... WebCurrent Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ruiwen Zhang ( UH Drug Discovery Institute). The journal covers research on contemporary molecular drug targets involved in cancer, including medicinal chemistry, pharmacology, molecular biology, genomics, and ... is kelly ripa off the air